<div id="readability-page-1"><p><span>DuPont de Nemours (NYSE:DD - Get Free Report)</span> had its target price lifted by investment analysts at Wolfe Research  from $44.00 to $49.00 in a note issued to investors on Friday,MarketScreener reports. The firm currently has an &#34;outperform&#34; rating on the basic materials company's stock. Wolfe Research's price objective indicates a potential upside of 14.27% from the stock's previous close.</p><div><p><span></span><span>Get <strong>DuPont de Nemours</strong> alerts:</span></p></div><ul><li>Consumers Got Coal, But Santa Dropped Off Big Gains for These 2 Retailers</li></ul><p>Several other equities analysts have also commented on DD. KeyCorp increased their price objective on DuPont de Nemours from $45.00 to $51.00 and gave the company an &#34;overweight&#34; rating in a research report on Friday, January 9th. JPMorgan Chase &amp; Co. upped their price target on shares of DuPont de Nemours from $48.00 to $50.00 and gave the company an &#34;overweight&#34; rating in a research report on Friday. UBS Group upped their price target on shares of DuPont de Nemours from $46.00 to $49.00 and gave the company a &#34;buy&#34; rating in a report on Wednesday, January 7th. Morgan Stanley dropped their target price on DuPont de Nemours from $80.00 to $44.00 in a research report on Monday, November 10th. Finally, Royal Bank Of Canada decreased their price target on shares of DuPont de Nemours from $100.00 to $48.00 and set an &#34;outperform&#34; rating for the company in a report on Tuesday, November 18th. Ten equities research analysts have rated the stock with a Buy rating, four have assigned  a Hold rating and one  has given a Sell rating to the company's stock. According to data from MarketBeat.com, the stock  has an average rating of &#34;Moderate Buy&#34; and an average target price of $45.53.</p><p><b>View Our Latest Report on DD</b></p><h2>DuPont de Nemours Price Performance</h2><ul><li>MarketBeat Week in Review – 11/03 - 11/07</li></ul><p>DD stock opened at $42.88 on Friday. DuPont de Nemours has a 1 year low of $22.50 and a 1 year high of $44.17. The stock's 50 day moving average price is $40.74 and its 200 day moving average price is $35.19. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.63 and a current ratio of 2.00. The firm has a market cap of $17.97 billion, a P/E ratio of -23.30, a PEG ratio of 3.22 and a beta of 1.08. </p><p>DuPont de Nemours (NYSE:DD - Get Free Report) last issued its quarterly earnings results on Thursday, November 6th. The basic materials company reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.05. DuPont de Nemours had a negative net margin of 6.17% and a positive return on equity of 7.81%. The firm had revenue of $3.07 billion for the quarter, compared to analyst estimates of $3.12 billion. During the same period in the previous year, the business earned $1.18 EPS. The company's revenue was down 2.9% compared to the same quarter last year. DuPont de Nemours has set its Q4 2025 guidance at 0.430-0.430 EPS.  On average, sell-side analysts expect that  DuPont de Nemours will post 4.38 earnings per share for the current fiscal year. </p><ul><li>DuPont's Spinoff Unlocks 2 Paths to Profit</li></ul><p>DuPont de Nemours declared that its board has approved a stock buyback program on Thursday, November 6th that authorizes the company to repurchase $2.00 billion in    shares. This repurchase authorization authorizes the basic materials company to repurchase up to 12.2% of its shares through open market purchases. Shares repurchase programs are often an indication that the company's management believes its stock is undervalued. </p><h2>Insider Buying and Selling</h2><p>In other DuPont de Nemours news, CEO Lori Koch sold 9,011 shares of the company's stock in a transaction on Friday, November 28th. The shares were sold at an average price of $39.46, for a total value of $355,574.06. Following the completion of the transaction, the chief executive officer owned 288,326 shares in the company, valued at $11,377,343.96. This represents a 3.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Erik T. Hoover sold 6,005 shares of the company's stock in a transaction that occurred on Friday, November 28th. The stock was sold at an average price of $39.79, for a total value of $238,938.95. Following the sale, the senior vice president owned 112,101 shares of the company's stock, valued at $4,460,498.79. This trade represents a 5.08% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own  0.61% of the company's stock. </p><h2>Institutional Trading of DuPont de Nemours</h2><p>A number of hedge funds and other institutional investors have recently made changes to their positions in DD. Princeton Global Asset Management LLC lifted its position in  DuPont de Nemours by 64.4% in the second quarter. Princeton Global Asset Management LLC now owns 365 shares of the basic materials company's stock valued at $25,000 after purchasing an additional 143 shares during the period.  Salomon &amp; Ludwin LLC increased its position in  DuPont de Nemours by 186.5% during the third quarter. Salomon &amp; Ludwin LLC now owns 318 shares of the basic materials company's stock worth $25,000 after buying an additional 207 shares in the last quarter.  Palisade Asset Management LLC acquired a new stake in  DuPont de Nemours in the third quarter valued at approximately $26,000.  Financial Life Planners bought a new position in  DuPont de Nemours during the 3rd quarter valued at $27,000.  Finally, Imprint Wealth LLC bought a new stake in  DuPont de Nemours during the third quarter valued at $27,000. Institutional investors and hedge funds own  73.96% of the company's stock. </p><h2>DuPont de Nemours Company Profile</h2> (Get Free Report)<p>DuPont de Nemours <span>NYSE: DD<span></span></span> is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.  </p><p>DuPont's operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than DuPont de Nemours</li><li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li><li>How a Family Trust May Be Able To Help Preserve Your Wealth</li><li>A U.S. “birthright” claim worth trillions - activated quietly</li><li>Executive Order 14330: Trump’s Biggest Yet</li><li>“Fed Proof” Your Bank Account with THESE 4 Simple Steps</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURE?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURE"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in DuPont de Nemours Right Now?</h2><p>Before you consider DuPont de Nemours, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DuPont de Nemours wasn't on the list.</p><p>While DuPont de Nemours currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Wolfe Research has raised its target price for DuPont de Nemours (NYSE:DD) from $44.00 to $49.00, maintaining an "outperform" rating. This suggests a potential upside of 14.27% from the stock's previous close. Other analysts have also increased their price targets, with an average target price of $45.53. DuPont reported $1.09 EPS for the last quarter, exceeding estimates, and announced a $2 billion stock buyback program. The stock opened at $42.88, with a 1-year high of $44.17 and a low of $22.50.</p>

DuPont de Nemours (NYSE:DD) Stock Price Expected to Rise, Wolfe Research Analyst Says